Related Experiment Video

Updated: Jul 29, 2026

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

[Modern antidepressants in complex management of patients with hypertension and concomitant affective disorders]

Iu A Vasiuk1, E A Nesterova, T V Dovzhenko

  • 1Moscow State Medical Dental University; ul. Delegatskaya 20, 103473 Moscow, Russia.

Kardiologiia
|September 2, 2004
PubMed

Insights

Hypertension patients often experience depression and anxiety, increasing disease risk. Combining antihypertensive drugs with modern antidepressants improves hypertension management and cardiac health.

Area of Science:

  • Cardiology
  • Psychiatry
  • Pharmacology

Background:

  • Over 50% of hypertension patients suffer from depression and anxiety.
  • Affective disorders accelerate hypertension progression.
  • Effective treatment requires integrated antihypertensive and antidepressant therapies.

Purpose of the Study:

  • To evaluate the impact of combined antihypertensive and antidepressant therapy on hypertension management.
  • To assess the safety and efficacy of this combination therapy.

Main Methods:

  • Utilized angiotensin-converting enzyme inhibitors (captopril) or beta-adrenoblockers (metoprolol) in combination with antidepressants.
  • Monitored clinical course, 24-hour blood pressure, intracardiac hemodynamics, and left ventricular parameters.

Main Results:

  • The combination therapy favorably influenced the clinical course of hypertension.
  • Improvements were observed in 24-hour blood pressure profiles and intracardiac hemodynamics.
  • Left ventricular structural and geometric parameters showed positive changes.
  • Sufficient antihypertensive effect was achieved with good tolerability.

Conclusions:

  • Combined therapy of antihypertensive drugs and antidepressants offers a beneficial approach to managing hypertension.
  • Modern antidepressants demonstrate a favorable safety profile in cardiac patients.
  • This integrated treatment strategy improves cardiovascular outcomes in hypertensive individuals with affective disorders.

More Related Videos

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder04:33

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder

Published on: April 26, 2024

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Anxiolytic Drugs: Overview01:26

Anxiolytic Drugs: Overview

Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications